Embed Size (px)
Citation preview
Regulatory guidelines for
promotion of
Prescription drugs in India.
©Mark IV Medical communication
The Organization of Pharmaceutical Producers of India (OPPI) has developed a code of practice for its members, based on the IFPMA.
©Mark IV Medical communication
• Sets out standards for ethical promotion of pharmaceutical products to healthcare professionals.
• Implementation of the code is a matter of self regulation and self discipline
©Mark IV Medical communication
Does NOT seek to regulate -
• Promotion of prescription drugs to consumers (DTC advertising).
• Promotion of self medication products (OTC medications).
• Provision of non promotional information.
©Mark IV Medical communication
Industry relationships with healthcare professionals must support, and be consistent with, the professional responsibilities that healthcare professionals have towards their patients.
Pharmaceutical companies must maintain high ethical standards when conducting promotional activities and comply with applicable legal and
professional requirements ©Mark IV Medical communication
All printed promotional materials other than reminder advertisements must be legible and include :
• the name of the product (normally the brand name),
• the active ingredients, • the name and address of the pharmaceutical
company or its marketing agent,• date of production of the advertisement,
• the abbreviated prescribing information.
©Mark IV Medical communication
This should include the following:
• Approved Indications
• Dose
• Method of use
• Succinct statement of contraindications, precautions and side effects
©Mark IV Medical communication
• Promotional material should not mislead by distortion, exaggeration, undue emphasis or omission, or in any other way
• Absolute or all-embracing claims should be used
with caution and only with adequate qualification and substantiation.
• Descriptions such as ‘safe’ and ‘no side effects’ should generally be avoided and should always be adequately qualified
©Mark IV Medical communication
Promotion should be capable of substantiation either by reference to the approved labeling or by scientific evidence. Such evidence should be made available, on request, to healthcare professionals.
©Mark IV Medical communication
It is a short advertisement consisting of • Name• Simple statement of indications to
designate therapeutic category
Such reminders may avoid API.
©Mark IV Medical communication
• Promotion should not be disguised. Clinical assessments, post-marketing surveillance and experience programmes, and post-authorization studies must not be disguised promotion.
• Material relating to pharmaceutical products and their uses, whether or
not promotional in nature, that is sponsored by a company should clearly indicate by whom it has been sponsored
©Mark IV Medical communication
• In accordance with local laws and regulations, free samples of a pharmaceutical product may be supplied to healthcare professionals in order to enhance patient care.
• Samples should not be resold or otherwise misused.
• Companies should have adequate systems of control and accountability for samples provided to healthcare professionals, including how to look after such samples while they are in the possession of medical representatives
©Mark IV Medical communication
Cash Payments in cash or cash equivalents (such as gift certificate) must not be offered to healthcare professionals.
Personal gifts Gifts for the personal benefit of healthcare professionals (including, but not limited to, music CDs, DVDs, sporting or entertainment tickets, electronic items) must not be provided or offered.
Cultural courtesy gifts An inexpensive gift not related to the practice of medicine may be given on an infrequent basis to healthcare professionals in acknowledgement of significant national, cultural or religious holidays.
©Mark IV Medical communication
• Promotional aids Promotional aids or reminder items may be
provided or offered to healthcare professionals and appropriate administrative staff, provided that the gift is of minimal value and relevant to the practice of the healthcare professional.
• Medical Utility items Items of medical utility may be offered or
provided free of charge, provided that such items are of modest value and beneficial to the provision of medical services and for patient care.
©Mark IV Medical communication
Including audiovisuals The same requirements that apply to
printed materials also apply to electronic promotional materials and websites.
©Mark IV Medical communication
• The identity of the pharmaceutical company and of the intended audience should be readily apparent.
• The content should be appropriate for the intended audience.
• The presentation (content, links, etc.) should be appropriate and apparent to the intended audience.
• India-specific information should comply with local laws and the Drugs and Magic remedies Act.
©Mark IV Medical communication
Limited to,
• Travel
• Meals
• Accommodation
• Registration fees©Mark IV Medical communication
• Companies should avoid using renowned or extravagant venues.
• Hospitality should be limited to moderate and reasonable refreshments and/or meals incidental to the main purpose of the event and should be provided only to participants in the event and not their guests.
©Mark IV Medical communication
• As a general rule, the hospitality provided should not exceed what healthcare professional recipients would normally be prepared to pay for themselves.
• No stand-alone entertainment or other leisure or social activities should be provided or paid for by member companies. At events, entertainment of modest nature, which is
secondary to refreshments and/or meals, is allowed.
©Mark IV Medical communication
Payments of reasonable fees and reimbursement may be provided to healthcare professionals who are providing genuine services as speakers or presenters on the basis of a written contract with the company at the event.
Other Healthcare professionals cannot be compensated for time spent in attending an event, e.g. a company-sponsored meeting or scientific congress.
©Mark IV Medical communication
Promotional material (excluding promotional aids) for a pharmaceutical product not registered in the country of the event should be accompanied by
• a suitable statement indicating the countries in which the product is registered,
• an explanatory statement indicating that registration conditions differ internationally.
©Mark IV Medical communication
•Medical Animation Library
•2D/3D Medical & Scientific Illustrations
•2D/3D Medical & Scientific Animations
•Flash based Interactive Applications
•Websites & Health Portals for Pharmaceutical & Healthcare Industry
Written by-Dr. Neelesh BhandariMD (Path), PGP Human RightsAdvisor (Medical Communications) Mark IV Medical Communications.http://tinyurl.com/drneelesh
©Mark IV Medical communication
INDIA20, Bharathi Park, 8th CrossSai Baba Mission PostCoimbatore 641011Tamil Nadu, Indiawww.markivmedical.comTelephone: +91 422 4385520Fax: +91 422 2430963Email: [email protected]
UNITED STATES225, West 36 Street Suite 800,New YorkNY 10018Telephone: +1 646 383 1570Fax: +1 646 519 2757Email: [email protected]
GERMANYRepresentative German OfficeFriedrichstrasse 11-1342781 Haan - GERMANY
Telephone: (+492129) 94 05-23Fax: (+492129) 94 05-20Email: [email protected]
UNITED KINGDOM2nd Floor,145-157St. John Street,London EC1V 4PY
Telephone: +44 020 3239Email: [email protected]
©Mark IV Medical communication
